| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.079 | 0.2 |